BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17967565)

  • 1. Serum apoptosis markers in acute liver failure: a pilot study.
    Rutherford AE; Hynan LS; Borges CB; Forcione DG; Blackard JT; Lin W; Gorman AR; Shaikh OS; Reuben A; Harrison E; Reddy KR; Le WM; Chung RT;
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1477-83. PubMed ID: 17967565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.
    Tagami A; Ohnishi H; Hughes RD
    Hepatogastroenterology; 2003; 50(51):742-5. PubMed ID: 12828076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure.
    Singhal S; Chakravarty A; Das BC; Kar P
    Biomarkers; 2009 Aug; 14(5):347-53. PubMed ID: 19505222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure.
    Lin SD; Kawakami T; Ushio A; Sato A; Sato S; Iwai M; Endo R; Takikawa Y; Suzuki K
    J Gastroenterol Hepatol; 2006 Feb; 21(2):374-80. PubMed ID: 16509861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H; Narita K; Endo S
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
    Aw MM; Mitry RR; Hughes RD; Dhawan A
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):224-7. PubMed ID: 17255836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis.
    Gotohda N; Iwagaki H; Ozaki M; Kinoshita T; Konishi M; Nakagohri T; Takahashi S; Saito S; Yagi T; Tanaka N
    Hepatogastroenterology; 2008; 55(85):1400-3. PubMed ID: 18795698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selected apoptotic markers in serum of patients with chronic viral hepatitis C.
    Głowacki MK; Cieśla A; Cibor D; Owczarek D; Mach T; Wiliński J; Wiliński B
    Przegl Lek; 2014; 71(7):369-73. PubMed ID: 25338331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.
    Antoniades CG; Berry PA; Davies ET; Hussain M; Bernal W; Vergani D; Wendon J
    Hepatology; 2006 Jul; 44(1):34-43. PubMed ID: 16799971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular cell adhesion molecule 1, soluble Fas and hepatocyte growth factor as predictors of mortality in nonagenarians: the Vitality 90+ study.
    Kämppä N; Mäkelä KM; Lyytikäinen LP; Peltonen N; Hautamäki J; Seppälä I; Mononen N; Goebeler S; Karhunen PJ; Hervonen A; Hurme M; Jylhä M; Lehtimäki T
    Exp Gerontol; 2013 Nov; 48(11):1167-72. PubMed ID: 23911532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
    Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
    Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine profiles in acute liver failure treated with albumin dialysis.
    Ilonen I; Koivusalo AM; Repo H; Höckerstedt K; Isoniemi H
    Artif Organs; 2008 Jan; 32(1):52-60. PubMed ID: 18181803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute liver failure is associated with elevated liver stiffness and hepatic stellate cell activation.
    Dechêne A; Sowa JP; Gieseler RK; Jochum C; Bechmann LP; El Fouly A; Schlattjan M; Saner F; Baba HA; Paul A; Dries V; Odenthal M; Gerken G; Friedman SL; Canbay A
    Hepatology; 2010 Sep; 52(3):1008-16. PubMed ID: 20684020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial evaluation of children with ALF with advanced MRI, serum proinflammatory cytokines, thiamine, and cognition assessment.
    Srivastava A; Yadav SK; Borkar VV; Yadav A; Yachha SK; Thomas MA; Rathore RK; Pandey CM; Gupta RK
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):580-6. PubMed ID: 22614112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of IL-18 and soluble fas in patients with postoperative hepatic failure.
    Nakae H; Zheng YJ; Wada H; Tajimi K; Endo S
    Eur Surg Res; 2003; 35(2):61-6. PubMed ID: 12679613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrotic cell death and suppression of T-cell immunity characterized acute liver failure due to drug-induced liver injury.
    Kakisaka K; Kataoka K; Suzuki Y; Okada Y; Yoshida Y; Kuroda H; Takikawa Y
    Cytokine; 2016 Oct; 86():21-28. PubMed ID: 27442007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis.
    Shiota G; Okano J; Umeki K; Kawasaki H; Kawamoto T; Nakamura T
    Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):157-62. PubMed ID: 7994560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated serum concentration of hepatocyte growth factor in patients with multiple myeloma: correlation with markers of disease activity.
    Alexandrakis MG; Passam FH; Sfiridaki A; Kandidaki E; Roussou P; Kyriakou DS
    Am J Hematol; 2003 Apr; 72(4):229-33. PubMed ID: 12666132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.